GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Financial Ratios History
[Consolidated]
Mar2025 | Mar2024 | |
---|---|---|
Operational & Financial Ratios | ||
Earnings Per Share (Rs) | 6.95 | 8.59 |
CEPS(Rs) | 9.05 | 10.29 |
DPS(Rs) | 0.10 | 0.10 |
Book NAV/Share(Rs) | 59.93 | 53.11 |
Tax Rate(%) | 26.02 | 25.53 |
Margin Ratios | ||
Core EBITDA Margin(%) | 12.37 | 15.67 |
EBIT Margin(%) | 10.78 | 14.09 |
Pre Tax Margin(%) | 8.56 | 12.30 |
PAT Margin (%) | 6.33 | 9.16 |
Cash Profit Margin (%) | 8.24 | 10.97 |
Performance Ratios | ||
ROA(%) | 6.16 | 7.88 |
ROE(%) | 12.29 | 16.17 |
ROCE(%) | 13.48 | 15.59 |
Asset Turnover(x) | 0.97 | 0.86 |
Sales/Fixed Asset(x) | 2.56 | 3.82 |
Working Capital/Sales(x) | 4.64 | 4.12 |
Efficiency Ratios | ||
Fixed Capital/Sales(x) | 0.39 | 0.26 |
Receivable days | 106.89 | 128.09 |
Inventory Days | 69.22 | 77.83 |
Payable days | 191.37 | 178.99 |
Valuation Parameters | ||
PER(x) | 48.44 | 32.96 |
PCE(x) | 37.19 | 27.53 |
Price/Book(x) | 5.61 | 5.33 |
Yield(%) | 0.03 | 0.04 |
EV/Net Sales(x) | 4.46 | 3.90 |
EV/Core EBITDA(x) | 26.16 | 21.03 |
EV/EBIT(x) | 30.80 | 23.73 |
EV/CE(x) | 4.01 | 3.70 |
M Cap / Sales | 4.12 | 3.52 |
Growth Ratio | ||
Net Sales Growth(%) | 1.63 | - |
Core EBITDA Growth(%) | -6.52 | - |
EBIT Growth(%) | -10.42 | - |
PAT Growth(%) | -19.14 | - |
EPS Growth(%) | -19.14 | - |
Financial Stability Ratios | ||
Total Debt/Equity(x) | 0.52 | 0.60 |
Current Ratio(x) | 1.61 | 1.61 |
Quick Ratio(x) | 1.05 | 1.08 |
Interest Cover(x) | 4.84 | 7.89 |
Total Debt/Mcap(x) | 0.09 | 0.11 |
Compare Financial Ratios of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,558.1 Cr | -4% | -0.6% | -13.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,218.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,158.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹126,710.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,586.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,496.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | -4% |
-0.6% |
-13.1% |
SENSEX | 1.6% |
2.1% |
2.6% |
You may also like the below Video Courses